Clinical Trials

70 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03647592 2023-12-27

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

Unknown

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06182800 2023-12-27

Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03991403 2023-04-03

Study of Atezolizumab Combination Carboplatin + Paclitaxel + Bevacizumab in EGRF Mutation or ALK Translocation NSCLC

228 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04974879 2023-03-29

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05104281 2023-03-29

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

60 enrolled

Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05754736 2023-03-06

Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations.

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05738317 2023-02-22

Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

50 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT05273814 2022-07-13

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Phase 1 Unknown

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02743923 2021-12-21

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

203 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04405674 2021-11-22

Tislelizumab Combined With Chemotherapy With or Without Bevacizumab in TKI-Resistant EGFR-Mutated Non-squamous NSCLC

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04944069 2021-06-29

ATTRACT

Phase NA Unknown

69 enrolled

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT04725448 2021-04-06

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

27 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Thoracic Neoplasms

NCT04425681 2020-06-11

OWBLM

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT04213170 2019-12-30

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

60 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT04175158 2019-11-22

Clinical Trial in Chinese Healthy Volunteers of GB222

Phase 1 Unknown

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04148898 2019-11-04

OWONBNSCLCLM

80 enrolled

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT03647956 2019-04-17

Atezolizumab in Combination With Bevacizumab, Carboplatin and Pemetrexed for EGFR-mutant Metastatic NSCLC Patients After Failure of EGFR Tyrosine Kinase Inhibitors

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03616691 2018-08-06

Atezolizumab Monotherapy and Consequent Therapy With Atezolizumab Plus Bevacizumab for NSCLC

46 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02655536 2018-07-10

BRILLIANT

109 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03533127 2018-07-10

A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer

648 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03195569 2017-06-22

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Unknown

15 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01980472 2017-02-27

Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02930954 2016-10-13

Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance

180 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02195336 2014-07-21

BevMar

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT02005120 2013-12-20

Intrapleural Administration of Bevacizumab Versus Endostar for Pleural Effusions in NSCLC

Carcinoma, Non-Small-Cell Lung

NCT01891708 2013-07-03

VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer

Unknown

40 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT00150657 2005-11-29

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer

45 enrolled